Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07537478 · ClinicalTrials.gov registry record
Respiration Measured Via End-tidal CO2 and Spirometry Study (RESPI)
A clinical trial, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07537478: Recruiting study, sponsored by Boston Scientific Corporation.
NCT07537478 is a clinical trial that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07537478 is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
To collect respiration data via end-tidal CO2 and spirometry and compare respiration rates measured via the two methods.
Primary Outcome
End-Tidal CO2 will be measured as a fractional concentration (volume percent of CO₂ in exhaled gas).
Interventions
- DEVICE Wearable Respiration mask - exercise
- DEVICE Wearable respiration Mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05-28 |
| Est. Completion | 2026-07 |
What NCT07537478 shows while recruiting
NCT07537478 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Wearable Respiration mask - exercise is the first listed.
NCT07537478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07537478 about?
NCT07537478 is a clinical study titled "Respiration Measured Via End-tidal CO2 and Spirometry Study (RESPI)". To collect respiration data via end-tidal CO2 and spirometry and compare respiration rates measured via the two methods.
What is the current status of trial NCT07537478?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-05-28. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07537478?
The interventions under investigation include: Wearable Respiration mask - exercise (DEVICE), Wearable respiration Mask (DEVICE).
Who is sponsoring clinical trial NCT07537478?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI